HBV infection, liver enzymes and their association with adverse liver disease and all-cause death: a matched retrospective cohort study in Eastern China
Open Access
Abstract
Background China has historically been a high-prevalence area for hepatitis B virus (HBV) infection, leading to a high incidence of adverse liver diseases and significant disease burden. However, comprehensive data on HBV infection and associated adverse liver diseases in the Chinese population remain limited. This study aimed to analyse the risk factors for adverse liver outcomes in patients who tested positive for hepatitis B surface antigen (HBsAg). Method A matched retrospective cohort study was conducted from 1 January to 30 September 2013 in Jiangshan and Shiqi towns in Yinzhou District, Ningbo, Zhejiang Province. Data were sourced from the Yinzhou Health Information System. HBsAg-positive patients were matched 1:2 by birth year, sex, town and calendar period with HBsAg-negative controls. Adverse liver diseases, including cirrhosis, liver cancer and liver failure, were identified as outcomes, with follow-up continuing until 31 December 2022. Cox proportional hazards models were used to assess the associations between HBV infection and the risks of adverse liver disease and all-cause mortality, adjusting for age, sex, education, location, tobacco use, alcohol consumption and physical activity. Results A total of 1, 454 HBsAg-positive patients and 2, 766 matched controls were included, with 29, 945 person-years of follow-up (median: 9.17 years). During follow-up, 99 participants developed adverse liver diseases and 73 died. Among HBsAg-positive individuals, the incidence rate of adverse liver disease was 8.21 (95% CI: 6.59 to 10.12) per 1000 person-years, with a 12.24-fold higher risk than HBsAg-negative individuals (95% CI: 6.74 to 22.21). The mortality rate was 3.91 (95% CI: 2.84 to 5.25) per 1, 000 person-years in HBsAg-positive patients, with a 2.28-fold higher risk of all-cause mortality compared with the HBsAg-negative group (95% CI: 1.35 to 3.85). Elevated alanine aminotransferase (ALT) levels were associated with higher risks of adverse liver disease (Model 1 HR: 2.48, 95% CI: 1.49 to 4.12; Model 2 HR: 2.46, 95% CI: 1.48 to 4.12) and all-cause mortality (Model 1 HR: 3.14, 95% CI: 1.50 to 6.60; Model 2 HR: 2.77, 95% CI: 1.29 to 5.92). Conclusion This study established a population-based cohort in eastern China using a big data platform for longitudinal follow-up. Our findings indicate that HBsAg-positive individuals face an increased risk of adverse liver outcomes and all-cause mortality, with elevated ALT serving as a significant risk marker. Enhanced HBV screening among the general population and increased ALT monitoring frequency in HBsAg-positive individuals are recommended.Keywords
Funding Information
- Ningbo Health Science and Technology Plan Project, China (2024KY1611)
- Chinese Founding for Hepatitis Prevention and Control (YGFK20230050)
- Ningbo Municipal Health Commission and Ningbo Municipal Bureau of Science and Technology (2023Y60)
This publication has 34 references indexed in Scilit:
- Real-World Primary Care Data Comparing ALT and FIB-4 in Predicting Future Severe Liver Disease OutcomesJournal of General Internal Medicine, 2023
- Global burden of primary liver cancer in 2020 and predictions to 2040Journal of Hepatology, 2022
- Countdown on hepatitis B elimination by 2030: the global burden of liver disease related to hepatitis B and association with socioeconomic statusHepatology International, 2022
- Trends in the disease burden of HBV and HCV infection in China from 1990-2019International Journal of Infectious Diseases, 2022
- High‐quality diet, physical activity, and college education are associated with low risk of NAFLD among the US populationHepatology, 2021
- Investigation of multidrug-resistance mutations of hepatitis B virus (HBV) in a large cohort of chronic HBV-infected patients with treatment of nucleoside/nucleotide analogsAntiviral Research, 2021
- The prevalence of occult HBV infection in immunized children with HBsAg-positive parents: a hospital-based analysisHepatology International, 2020
- The association between education level and chronic liver disease of any etiologyEuropean Journal of Internal Medicine, 2020
- International trends in hepatocellular carcinoma incidence, 1978–2012International Journal of Cancer, 2019
- Risk of Hepatocellular Carcinoma Across a Biological Gradient of Serum Hepatitis B Virus DNA LevelJAMA, 2006